Live Attenuated Veterinary Vaccines Market Report – Research, Industry Analysis Reports and Market Demands

Global Live Attenuated Veterinary Vaccines Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Live Attenuated Veterinary Vaccines Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Poultry
- 1.3.3 Ruminants
- 1.3.4 Feline
- 1.3.5 Canine
1.4 Market Analysis by Pathogen
- 1.4.1 Overview: Global Live Attenuated Veterinary Vaccines Consumption Value by Pathogen: 2021 Versus 2025 Versus 2032
- 1.4.2 Viral Live Attenuated Vaccines
- 1.4.3 Bacterial Live Attenuated Vaccines
- 1.4.4 Parasitic Live Attenuated Vaccines
1.5 Market Analysis by Vaccine Combination
- 1.5.1 Overview: Global Live Attenuated Veterinary Vaccines Consumption Value by Vaccine Combination: 2021 Versus 2025 Versus 2032
- 1.5.2 Monovalent Live Attenuated Vaccines
- 1.5.3 Multivalent Live Attenuated Vaccines
- 1.5.4 Combination Live Attenuated Vaccines
1.6 Market Analysis by Application
- 1.6.1 Overview: Global Live Attenuated Veterinary Vaccines Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Veterinary Hospital
- 1.6.3 Laboratory
- 1.6.4 CROs
- 1.6.5 Others
1.7 Global Live Attenuated Veterinary Vaccines Market Size & Forecast
- 1.7.1 Global Live Attenuated Veterinary Vaccines Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Live Attenuated Veterinary Vaccines Sales Quantity (2021-2032)
- 1.7.3 Global Live Attenuated Veterinary Vaccines Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Live Attenuated Veterinary Vaccines by Manufacturer

3.1 Global Live Attenuated Veterinary Vaccines Sales Quantity by Manufacturer (2021-2026)
3.2 Global Live Attenuated Veterinary Vaccines Revenue by Manufacturer (2021-2026)
3.3 Global Live Attenuated Veterinary Vaccines Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Live Attenuated Veterinary Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Live Attenuated Veterinary Vaccines Manufacturer Market Share in 2025
- 3.4.3 Top 6 Live Attenuated Veterinary Vaccines Manufacturer Market Share in 2025
3.5 Live Attenuated Veterinary Vaccines Market: Overall Company Footprint Analysis
- 3.5.1 Live Attenuated Veterinary Vaccines Market: Region Footprint
- 3.5.2 Live Attenuated Veterinary Vaccines Market: Company Product Type Footprint
- 3.5.3 Live Attenuated Veterinary Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Live Attenuated Veterinary Vaccines Market Size by Region
- 4.1.1 Global Live Attenuated Veterinary Vaccines Sales Quantity by Region (2021-2032)
- 4.1.2 Global Live Attenuated Veterinary Vaccines Consumption Value by Region (2021-2032)
- 4.1.3 Global Live Attenuated Veterinary Vaccines Average Price by Region (2021-2032)
4.2 North America Live Attenuated Veterinary Vaccines Consumption Value (2021-2032)
4.3 Europe Live Attenuated Veterinary Vaccines Consumption Value (2021-2032)
4.4 Asia-Pacific Live Attenuated Veterinary Vaccines Consumption Value (2021-2032)
4.5 South America Live Attenuated Veterinary Vaccines Consumption Value (2021-2032)
4.6 Middle East & Africa Live Attenuated Veterinary Vaccines Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Live Attenuated Veterinary Vaccines Sales Quantity by Type (2021-2032)
5.2 Global Live Attenuated Veterinary Vaccines Consumption Value by Type (2021-2032)
5.3 Global Live Attenuated Veterinary Vaccines Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Live Attenuated Veterinary Vaccines Sales Quantity by Application (2021-2032)
6.2 Global Live Attenuated Veterinary Vaccines Consumption Value by Application (2021-2032)
6.3 Global Live Attenuated Veterinary Vaccines Average Price by Application (2021-2032)

7 North America

7.1 North America Live Attenuated Veterinary Vaccines Sales Quantity by Type (2021-2032)
7.2 North America Live Attenuated Veterinary Vaccines Sales Quantity by Application (2021-2032)
7.3 North America Live Attenuated Veterinary Vaccines Market Size by Country
- 7.3.1 North America Live Attenuated Veterinary Vaccines Sales Quantity by Country (2021-2032)
- 7.3.2 North America Live Attenuated Veterinary Vaccines Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Live Attenuated Veterinary Vaccines Sales Quantity by Type (2021-2032)
8.2 Europe Live Attenuated Veterinary Vaccines Sales Quantity by Application (2021-2032)
8.3 Europe Live Attenuated Veterinary Vaccines Market Size by Country
- 8.3.1 Europe Live Attenuated Veterinary Vaccines Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Live Attenuated Veterinary Vaccines Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Live Attenuated Veterinary Vaccines Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Live Attenuated Veterinary Vaccines Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Live Attenuated Veterinary Vaccines Market Size by Region
- 9.3.1 Asia-Pacific Live Attenuated Veterinary Vaccines Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Live Attenuated Veterinary Vaccines Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Live Attenuated Veterinary Vaccines Sales Quantity by Type (2021-2032)
10.2 South America Live Attenuated Veterinary Vaccines Sales Quantity by Application (2021-2032)
10.3 South America Live Attenuated Veterinary Vaccines Market Size by Country
- 10.3.1 South America Live Attenuated Veterinary Vaccines Sales Quantity by Country (2021-2032)
- 10.3.2 South America Live Attenuated Veterinary Vaccines Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Live Attenuated Veterinary Vaccines Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Live Attenuated Veterinary Vaccines Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Live Attenuated Veterinary Vaccines Market Size by Country
- 11.3.1 Middle East & Africa Live Attenuated Veterinary Vaccines Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Live Attenuated Veterinary Vaccines Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Live Attenuated Veterinary Vaccines Market Drivers
12.2 Live Attenuated Veterinary Vaccines Market Restraints
12.3 Live Attenuated Veterinary Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Live Attenuated Veterinary Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Live Attenuated Veterinary Vaccines
13.3 Live Attenuated Veterinary Vaccines Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Live Attenuated Veterinary Vaccines Typical Distributors
14.3 Live Attenuated Veterinary Vaccines Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Live Attenuated Veterinary Vaccines market size was valued at US$ 453 million in 2025 and is forecast to a readjusted size of US$ 773 million by 2032 with a CAGR of 8.2% during review period.
In 2025, global Live Attenuated Veterinary Vaccine approximately 16,943 k doses, with an average global market price of around US$ 26 per dose. Gross margin is about 47%. The cost is 14 usd. The Production is about 25,000 k doses. Live attenuated veterinary vaccines are biological products used to prevent infectious diseases in animals. They are made from pathogens that have been artificially weakened so that their disease-causing ability is greatly reduced while their capacity to stimulate an immune response remains. These vaccines usually provide strong and long-lasting immune protection and are widely used in poultry, swine, cattle, sheep, companion animals, and other animal disease prevention programs. Compared with inactivated vaccines, live attenuated vaccines often require lower doses and can induce faster immune responses, but they also require stricter control over production, storage, transportation, safety, and stability.
Live attenuated veterinary vaccines will develop toward greater safety, stability, precision, and efficiency. As large-scale farming and animal disease prevention requirements continue to rise, manufacturers will focus more on attenuation stability, duration of immunity, cross-protection, and cold-chain stability to reduce risks such as reversion to virulence, shedding, and environmental transmission. At the same time, genetic attenuation, reverse genetics, vector-based vaccines, and multivalent combination vaccines will drive product innovation, enabling broader protection against multiple pathogens or serotypes. In application, mass vaccination methods such as spray, drinking water, and intranasal delivery will become more widely used and integrated with digital disease monitoring and precise vaccination programs to improve efficiency across poultry, swine, cattle, sheep, and companion animal markets.
This report is a detailed and comprehensive analysis for global Live Attenuated Veterinary Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Live Attenuated Veterinary Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Live Attenuated Veterinary Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Live Attenuated Veterinary Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Live Attenuated Veterinary Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Live Attenuated Veterinary Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Live Attenuated Veterinary Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Ceva Santé Animale, Boehringer Ingelheim Animal Health, MSD Animal Health, Virbac, HIPRA, Vetoquinol, Phibro Animal Health, IDT Biologika, Vaxxinova, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Live Attenuated Veterinary Vaccines market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Poultry
Ruminants
Feline
Canine
Market segment by Pathogen
Viral Live Attenuated Vaccines
Bacterial Live Attenuated Vaccines
Parasitic Live Attenuated Vaccines
Market segment by Vaccine Combination
Monovalent Live Attenuated Vaccines
Multivalent Live Attenuated Vaccines
Combination Live Attenuated Vaccines
Market segment by Application
Veterinary Hospital
Laboratory
CROs
Others
Major players covered
Zoetis
Ceva Santé Animale
Boehringer Ingelheim Animal Health
MSD Animal Health
Virbac
HIPRA
Vetoquinol
Phibro Animal Health
IDT Biologika
Vaxxinova
KBNP Inc.
China Pharmaceutical Group Animal Health Co., Ltd.
Jinyu Bio-technology Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Live Attenuated Veterinary Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Live Attenuated Veterinary Vaccines, with price, sales quantity, revenue, and global market share of Live Attenuated Veterinary Vaccines from 2021 to 2026.
Chapter 3, the Live Attenuated Veterinary Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Live Attenuated Veterinary Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Live Attenuated Veterinary Vaccines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Live Attenuated Veterinary Vaccines.
Chapter 14 and 15, to describe Live Attenuated Veterinary Vaccines sales channel, distributors, customers, research findings and conclusion.

Buy now